長期投資家のためのIR情報
バリュートレンド

【4553】東和薬品
ジェネリック医薬品。循環器、呼吸器など。本社は大阪府。

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2027.03 2026/08/06 Q1予 304,000 → 0.0% 0.0% 32,000 → 0.0% 0.0% 30,000 → 0.0% 0.0% 21,500 → 0.0% 0.0%
2027.03 2026/05/14 当初予 304,000 - - - 32,000 - - - 30,000 - - - 21,500 - - -
2026.03 2026/05/14 実 273,710 ↑ +0.0% -2.2% 23,102 ↑ +0.0% -14.4% 28,079 ↑ +0.3% +11.0% 5,250 ↑ +1.0% -70.3%
2026.03 2026/05/11 修正予 273,700 ↓ -2.2% -2.2% 23,100 ↓ -14.4% -14.4% 28,000 ↑ +10.7% +10.7% 5,200 ↓ -70.6% -70.6%
2026.03 2026/02/13 Q3予 280,000 → 0.0% 0.0% 27,000 → 0.0% 0.0% 25,300 → 0.0% 0.0% 17,700 → 0.0% 0.0%
2026.03 2025/11/10 Q2予 280,000 → 0.0% 0.0% 27,000 → 0.0% 0.0% 25,300 → 0.0% 0.0% 17,700 → 0.0% 0.0%
2026.03 2025/08/07 Q1予 280,000 → 0.0% 0.0% 27,000 → 0.0% 0.0% 25,300 → 0.0% 0.0% 17,700 → 0.0% 0.0%
2026.03 2025/05/15 当初予 280,000 - - - 27,000 - - - 25,300 - - - 17,700 - - -
2025.03 2025/05/15 実 259,594 ↑ +0.0% -0.7% 23,242 ↑ +0.2% +29.1% 26,152 ↑ +0.2% +48.6% 18,986 ↑ +0.5% +63.7%
2025.03 2025/05/07 修正予 259,500 ↓ -1.0% -0.8% 23,200 ↓ -0.4% +28.9% 26,100 ↑ +15.0% +48.3% 18,900 ↑ +26.0% +62.9%
2025.03 2025/02/13 Q3予 262,100 → 0.0% +0.2% 23,300 → 0.0% +29.4% 22,700 → 0.0% +29.0% 15,000 → 0.0% +29.3%
2025.03 2024/11/12 Q2予 262,100 → 0.0% +0.2% 23,300 → 0.0% +29.4% 22,700 → 0.0% +29.0% 15,000 → 0.0% +29.3%
2025.03 2024/11/05 修正予 262,100 ↑ +0.2% +0.2% 23,300 ↑ +18.9% +29.4% 22,700 ↑ +18.2% +29.0% 15,000 ↑ +19.0% +29.3%
2025.03 2024/08/08 Q1予 261,500 → 0.0% 0.0% 19,600 ↑ +8.9% +8.9% 19,200 ↑ +9.1% +9.1% 12,600 ↑ +8.6% +8.6%
2025.03 2024/05/14 当初予 261,500 - - - 18,000 - - - 17,600 - - - 11,600 - - -
2024.03 2024/05/14 実 227,934 ↓ -0.5% +5.4% 17,647 ↑ +13.9% +49.6% 24,477 ↑ +25.5% +112.8% 16,173 ↑ +24.4% +134.4%
2024.03 2024/02/13 Q3予 229,000 ↑ +5.9% +5.9% 15,500 ↑ +31.4% +31.4% 19,500 ↑ +69.6% +69.6% 13,000 ↑ +88.4% +88.4%
2024.03 2023/11/13 Q2予 216,300 → 0.0% 0.0% 11,800 → 0.0% 0.0% 11,500 → 0.0% 0.0% 6,900 → 0.0% 0.0%
2024.03 2023/08/10 Q1予 216,300 → 0.0% 0.0% 11,800 → 0.0% 0.0% 11,500 → 0.0% 0.0% 6,900 → 0.0% 0.0%
2024.03 2023/05/15 当初予 216,300 - - - 11,800 - - - 11,500 - - - 6,900 - - -
2023.03 2023/05/15 実 208,859 ↓ -0.0% -1.7% 5,514 ↑ +0.3% -71.0% 5,141 ↑ +0.8% -72.9% 2,201 ↑ +0.0% -81.7%
2023.03 2023/05/10 修正予 208,900 ↓ -1.7% -1.7% 5,500 ↓ -30.4% -71.1% 5,100 ↓ -32.0% -73.2% 2,200 ↓ -40.5% -81.7%
2023.03 2023/02/13 Q3予 212,500 ↑ +8.2% 0.0% 7,900 ↓ -9.2% -58.4% 7,500 ↓ -7.4% -60.5% 3,700 ↓ -17.8% -69.2%
2023.03 2023/02/07 修正予 196,400 → 0.0% -7.6% 8,700 → 0.0% -54.2% 8,100 ↓ -23.6% -57.4% 4,500 ↓ -28.6% -62.5%
2023.03 2022/11/14 Q2予 196,400 ↓ -7.6% -7.6% 8,700 ↓ -54.2% -54.2% 10,600 ↓ -44.2% -44.2% 6,300 ↓ -47.5% -47.5%
2023.03 2022/08/10 Q1予 212,500 → 0.0% 0.0% 19,000 → 0.0% 0.0% 19,000 → 0.0% 0.0% 12,000 → 0.0% 0.0%
2023.03 2022/05/13 当初予 212,500 - - - 19,000 - - - 19,000 - - - 12,000 - - -
2022.03 2022/05/13 実 165,615 ↓ -0.7% +0.4% 19,205 ↓ -0.5% +10.4% 22,739 ↑ +2.8% +29.2% 15,914 ↑ +3.1% +32.6%
2022.03 2022/02/14 Q3予 166,700 → 0.0% +1.0% 19,300 → 0.0% +10.9% 22,110 → 0.0% +25.6% 15,440 → 0.0% +28.7%
2022.03 2021/11/12 Q2予 166,700 → 0.0% +1.0% 19,300 → 0.0% +10.9% 22,110 → 0.0% +25.6% 15,440 → 0.0% +28.7%
2022.03 2021/10/26 修正予 166,700 ↑ +1.0% +1.0% 19,300 ↑ +10.9% +10.9% 22,110 ↑ +25.6% +25.6% 15,440 ↑ +28.7% +28.7%
2022.03 2021/08/12 Q1予 165,000 → 0.0% 0.0% 17,400 → 0.0% 0.0% 17,600 → 0.0% 0.0% 12,000 → 0.0% 0.0%
2022.03 2021/05/14 当初予 165,000 - - - 17,400 - - - 17,600 - - - 12,000 - - -
2021.03 2021/05/14 実 154,900 ↑ +1.2% +3.3% 19,923 ↑ +2.2% +39.3% 18,677 ↑ +6.7% +26.2% 13,958 ↑ +10.8% +34.2%
2021.03 2021/02/12 Q3予 153,000 ↑ +2.0% +2.0% 19,500 ↑ +36.4% +36.4% 17,500 ↑ +18.2% +18.2% 12,600 ↑ +21.2% +21.2%
2021.03 2020/11/13 Q2予 150,000 → 0.0% 0.0% 14,300 → 0.0% 0.0% 14,800 → 0.0% 0.0% 10,400 → 0.0% 0.0%
2021.03 2020/08/13 Q1予 150,000 → 0.0% 0.0% 14,300 → 0.0% 0.0% 14,800 → 0.0% 0.0% 10,400 → 0.0% 0.0%
2021.03 2020/05/14 当初予 150,000 - - - 14,300 - - - 14,800 - - - 10,400 - - -
2020.03 2020/05/14 実 110,384 ↑ +0.3% -0.6% 16,143 ↑ +0.9% +11.3% 20,990 ↑ +2.4% +43.8% 14,503 ↑ +3.6% +39.5%
2020.03 2020/04/30 修正予 110,000 ↓ -0.9% -0.9% 16,000 ↑ +10.3% +10.3% 20,500 ↑ +40.4% +40.4% 14,000 ↑ +34.6% +34.6%
2020.03 2020/02/12 Q3予 111,000 → 0.0% 0.0% 14,500 → 0.0% 0.0% 14,600 → 0.0% 0.0% 10,400 → 0.0% 0.0%
2020.03 2019/11/11 Q2予 111,000 → 0.0% 0.0% 14,500 → 0.0% 0.0% 14,600 → 0.0% 0.0% 10,400 → 0.0% 0.0%
2020.03 2019/08/09 Q1予 111,000 → 0.0% 0.0% 14,500 → 0.0% 0.0% 14,600 → 0.0% 0.0% 10,400 → 0.0% 0.0%
2020.03 2019/05/14 当初予 111,000 - - - 14,500 - - - 14,600 - - - 10,400 - - -
2019.03 2019/05/14 実 105,104 ↑ +1.1% +8.4% 15,968 ↑ +6.5% +64.6% 18,865 ↑ +15.7% +96.5% 13,475 ↑ +17.2% +92.5%
2019.03 2019/02/12 Q3予 104,000 ↑ +1.2% +7.2% 15,000 ↑ +25.0% +54.6% 16,300 ↑ +33.6% +69.8% 11,500 ↑ +28.5% +64.3%
2019.03 2018/11/12 Q2予 102,800 → 0.0% +6.0% 12,000 → 0.0% +23.7% 12,200 → 0.0% +27.1% 8,950 → 0.0% +27.9%
2019.03 2018/10/29 修正予 102,800 ↑ +6.0% +6.0% 12,000 ↑ +23.7% +23.7% 12,200 ↑ +27.1% +27.1% 8,950 ↑ +27.9% +27.9%
2019.03 2018/08/10 Q1予 97,000 → 0.0% 0.0% 9,700 → 0.0% 0.0% 9,600 → 0.0% 0.0% 7,000 → 0.0% 0.0%
2019.03 2018/05/14 当初予 97,000 - - - 9,700 - - - 9,600 - - - 7,000 - - -
2018.03 2018/05/14 実 93,430 ↑ +0.0% -0.6% 11,643 ↓ -1.3% +35.4% 11,717 ↑ +0.1% +37.8% 6,495 ↓ -0.1% +12.0%
2018.03 2018/04/27 修正予 93,400 ↓ -0.6% -0.6% - - - - 11,700 ↓ -2.5% +37.6% 6,500 ↓ -22.6% +12.1%
2018.03 2018/02/13 修正予 94,000 → 0.0% 0.0% 11,800 ↑ +37.2% +37.2% 12,000 ↑ +41.2% +41.2% 8,400 ↑ +44.8% +44.8%
2018.03 2017/11/13 Q2予 94,000 → 0.0% 0.0% 8,600 → 0.0% 0.0% 8,500 → 0.0% 0.0% 5,800 → 0.0% 0.0%
2018.03 2017/08/07 Q1予 94,000 → 0.0% 0.0% 8,600 → 0.0% 0.0% 8,500 → 0.0% 0.0% 5,800 → 0.0% 0.0%
2018.03 2017/05/15 当初予 94,000 - - - 8,600 - - - 8,500 - - - 5,800 - - -
2017.03 2017/05/15 実 84,949 ↑ +0.1% -9.1% 6,869 ↑ +1.0% -34.6% 7,417 ↑ +0.2% -28.3% 5,576 ↑ +1.4% -25.2%
2017.03 2017/05/02 修正予 84,900 ↓ -4.0% -9.2% 6,800 ↓ -5.6% -35.2% 7,400 ↑ +45.1% -28.5% 5,500 ↑ +52.8% -26.2%
2017.03 2017/02/13 Q3予 88,400 → 0.0% -5.5% 7,200 → 0.0% -31.4% 5,100 → 0.0% -50.7% 3,600 → 0.0% -51.7%
2017.03 2016/10/28 修正予 88,400 ↓ -5.5% -5.5% 7,200 ↓ -31.4% -31.4% 5,100 ↓ -50.7% -50.7% 3,600 ↓ -51.7% -51.7%
2017.03 2016/05/13 当初予 93,500 - - - 10,500 - - - 10,350 - - - 7,450 - - -
2016.03 2016/05/13 実 82,115 ↑ +0.1% +0.1% 11,134 ↓ -3.2% -3.2% 10,157 ↓ -11.7% -11.7% 7,684 ↓ -6.3% -6.3%
2016.03 2016/02/08 Q3予 82,000 → 0.0% 0.0% 11,500 → 0.0% 0.0% 11,500 → 0.0% 0.0% 8,200 → 0.0% 0.0%
2016.03 2015/11/09 Q2予 82,000 → 0.0% 0.0% 11,500 → 0.0% 0.0% 11,500 → 0.0% 0.0% 8,200 → 0.0% 0.0%
2016.03 2015/08/10 Q1予 82,000 → 0.0% 0.0% 11,500 - - - 11,500 → 0.0% 0.0% 8,200 → 0.0% 0.0%
2016.03 2015/05/14 当初予 82,000 - - - - - - - 11,500 - - - 8,200 - - -
2015.03 2015/05/14 実 - - - - - - - - - - - - - - - -
2015.03 2015/04/30 修正予 71,400 ↓ -0.8% -0.8% - - - - 15,400 ↑ +40.0% +97.4% 11,050 ↑ +37.1% +108.5%
2015.03 2015/02/09 Q3予 72,000 → 0.0% 0.0% 10,000 ↑ +28.2% +28.2% 11,000 ↑ +41.0% +41.0% 8,060 ↑ +52.1% +52.1%
2015.03 2014/11/10 Q2予 72,000 → 0.0% 0.0% 7,800 → 0.0% 0.0% 7,800 → 0.0% 0.0% 5,300 → 0.0% 0.0%
2015.03 2014/08/08 Q1予 72,000 → 0.0% 0.0% - - - - 7,800 → 0.0% 0.0% 5,300 → 0.0% 0.0%
2015.03 2014/05/14 当初予 72,000 - - - 7,800 - - - 7,800 - - - 5,300 - - -
2014.03 2014/05/14 実 61,351 ↑ +0.1% +0.1% 7,706 ↓ -14.4% -14.4% 8,834 ↓ -8.9% -8.9% 5,992 ↓ -9.2% -9.2%
2014.03 2014/02/10 当初予 61,300 - - - 9,000 - - - 9,700 - - - 6,600 - - -
シェア ツイート
ページトップへ戻る